Sign in Pull a receipt

BCYC

BICYCLE THERAPEUTICS PLC

Biotechnology · Biotechnology

$110.97 sample

+0.35 (+0.32%) 1D

Market cap

$424.5B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-26

Alerts

8

Price$110.97 -2.95% 3M daily closessample

118.19108.00

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26SECDEF 14A filed
Oct 21SEC10-Q filed
Oct 16INSInsider sell: Chief Executive Officer
Oct 08SEC8-K filed: material event
Oct 02SEC10-Q filed
Sep 25INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: EVP, Operations
Sep 10INSInsider buy: Director

Sign up to see the real BCYC record →

Company facts

SEC EDGAR registration

Name: BICYCLE THERAPEUTICS PLC
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -53sample, -100 to +100
Reporting currency: USD

Who is positioning in BCYC

sample

Insiders: 15 insider transactions over 90 days, net selling, $116.4M
Congress: 4 members traded over 90 days
Institutions · 13F: 18 funds hold $10.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$28.2B +16.9% y/y

Q4 2024Q3 2026

Inventory$16.6B +12.0% y/y

Q4 2024Q3 2026

Accounts receivable$12.3B +6.1% y/y

Q4 2024Q3 2026

Total debt$33.6B +15.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $115.3B +11.2% 3M
Sample peer B: $253.4B -2.5% 3M
Sample peer C: $355.3B +2.0% 3M
Sample peer D: $61.4B +10.9% 3M
Sample peer E: $368.2B +0.7% 3M